Epidemiology of Type 2 Diabetes

Diabetes and Cancer Epidemiology

Author(s): Xianghai Zhou

Pp: 98-104 (7)

DOI: 10.2174/978160805361211201010098

* (Excluding Mailing and Handling)


It has been proposed that diabetes was associated with an increased risk of cancer mortality and morbidity. Complex mechanisms are involved in the association between diabetes and cancer. Metformin has been suggested to reduce the risk of cancer incidence (Hazard ratio 0.63 (95% CI 0.53- 0.75)) or cancer mortality (Hazard ratio 0.43 (95% CI 0.23-0.80)), but insulin or sulfonylurea is suspected to increase the risk of cancer incidence (Hazard ratio 1.36 (95% CI 1.19-1.54)) or cancer mortality (Hazard ratio 1.30 (95% CI 1.10-1.60)). Evidences on these issues are reviewed and summarized in this chapter.

Keywords: Diabetes, anti-diabetic drugs, cancer motality and morbidity.

Related Journals
Related Books
© 2024 Bentham Science Publishers | Privacy Policy